These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10338380)

  • 21. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nonredundant role for the adapter protein Shc in thymic T cell development.
    Zhang L; Camerini V; Bender TP; Ravichandran KS
    Nat Immunol; 2002 Aug; 3(8):749-55. PubMed ID: 12101399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
    Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
    Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.
    Song RX; McPherson RA; Adam L; Bao Y; Shupnik M; Kumar R; Santen RJ
    Mol Endocrinol; 2002 Jan; 16(1):116-27. PubMed ID: 11773443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.
    Baumann G; Maier D; Freuler F; Tschopp C; Baudisch K; Wienands J
    Eur J Immunol; 1994 Aug; 24(8):1799-807. PubMed ID: 7519995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling via Shc family adapter proteins.
    Ravichandran KS
    Oncogene; 2001 Oct; 20(44):6322-30. PubMed ID: 11607835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
    Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
    J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis and successful aging.
    Zhang Y; Herman B
    Mech Ageing Dev; 2002 Mar; 123(6):563-5. PubMed ID: 11850019
    [No Abstract]   [Full Text] [Related]  

  • 29. Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor.
    Shakibaei M; John T; De Souza P; Rahmanzadeh R; Merker HJ
    Biochem J; 1999 Sep; 342 Pt 3(Pt 3):615-23. PubMed ID: 10477272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human high-affinity immunoglobulin G receptor activates SH2-containing inositol phosphatase (SHIP).
    Cameron AJ; Allen JM
    Immunology; 1999 Aug; 97(4):641-7. PubMed ID: 10457218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 5 signals through Shc and Grb2 in human eosinophils.
    Bates ME; Busse WW; Bertics PJ
    Am J Respir Cell Mol Biol; 1998 Jan; 18(1):75-83. PubMed ID: 9448048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
    Purkerson JM; Parker DC
    J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
    Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
    Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptor proteins in lymphocyte activation.
    Janssen E; Zhang W
    Curr Opin Immunol; 2003 Jun; 15(3):269-76. PubMed ID: 12787751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of receptor-mediated signals in T cells by transmembrane adaptor proteins.
    Schraven B; Marie-Cardine A; Hübener C; Bruyns E; Ding I
    Immunol Today; 1999 Oct; 20(10):431-4. PubMed ID: 10500287
    [No Abstract]   [Full Text] [Related]  

  • 37. Lnk adaptor: novel negative regulator of B cell lymphopoiesis.
    Rudd CE
    Sci STKE; 2001 Jun; 2001(85):pe1. PubMed ID: 11752654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adapter proteins in T cell activation.
    Koretzky GA; Boerth NJ
    Cell Mol Life Sci; 1999 Dec; 56(11-12):1048-60. PubMed ID: 11212321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling at the immune synapse: vesicular trafficking takes the stage.
    Masi G; Baldari CT
    Cell Mol Immunol; 2013 Nov; 10(6):459-62. PubMed ID: 24037185
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of adaptor proteins in lymphocyte activation.
    Togni M; Lindquist J; Gerber A; Kölsch U; Hamm-Baarke A; Kliche S; Schraven B
    Mol Immunol; 2004 Jul; 41(6-7):615-30. PubMed ID: 15219999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.